publication venue for
- Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials 2010
- Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis 2009
- Epiadryamicin concentration in experimental hepatic metastases after bolus or continous infusion through systemic or locoregional routes 2003
- Epirubicin and its metabolites levels in experimental liver metastases after different administration routes. 2003
- Natural history of the neoplastic locoregional disease: Clinical and pathological patterns 2003
- A PREDICTIVE ASSAY FOR INDIVIDUAL PATIENT RESPONSE OF ESOPHAGEAL-CARCINOMA TO CHEMORADIOTHERAPY 1995
- A predictive assay for individual patient response of oesophageal carcinoma to chemoradiotherapy 1995
- Repurposed AT9283 triggers anti-tumoral effects by targeting MKK3 oncogenic functions in Colorectal Cancer.. 43:234. 2024
- The landscape of circulating tumor HPV DNA and TTMV-HPVDNA for surveillance of HPV-oropharyngeal carcinoma: systematic review and meta-analysis. 43:215. 2024
- The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers. 43:198. 2024
- Correction: Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer. 42:278. 2023
- A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer. 42:187. 2023
- The new world of RNA diagnostics and therapeutics. 42:189. 2023
- Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids. 42:170. 2023
- PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity. 42:2. 2023
- Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction. 41:51. 2022
- Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial. 41:255. 2022
- Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer. 41:151. 2022
- Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction. 41. 2022
- Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma. 40:344. 2021
- José Baselga M.D., Ph.D. (1959–2021) leading cancer researcher and oncologist. 40:156. 2021
- YAP and endothelin-1 signaling: an emerging alliance in cancer. 40:27. 2021
- Arenavirus as a potential etiological agent of odontogenic tumours in humans. 39:34. 2020
- Cancer at the time of the COVID-19 hurricane. 39:74. 2020
- Oral mucositis: the hidden side of cancer therapy. 39:210. 2020
- TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients. 39:200. 2020
- TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients. 39:111. 2020
- Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma. 38:349. 2019
- Targeting mutant p53 in cancer: the latest insights. 38:290. 2019
- miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells. 38:141. 2019
- New therapeutic strategies to treat human cancers expressing mutant p53 proteins. 37:30. 2018
- Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study. 37:95. 2018
- Che-1 sustains hypoxic response of colorectal cancer cells by affecting Hif-1α stabilization. 36:32. 2017
- In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells. 36:76. 2017
- SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiation. 31:7. 2012
- Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway. 30:103. 2011
- An algorithm to discover gene signatures with predictive potential. 29:120. 2010
- Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis. 28:112. 2009
- Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review. 27:21-21. 2008
- Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review. 27:4-4. 2008
- Systematic reviews for the Journal of Experimental & Clinical Cancer Research: going where the science takes us.. 26:169-174. 2007
- Oral anticoagulation may prolong survival of a subgroup of patients with cancer: a cochrane systematic review. 26:175-175. 2007
- Epiadryamicin concentration in experimental hepatic metastases after bolus or continous infusion through systemic or locoregional routes.. 22:229-232. 2003
- BCL-2: the pendulum of the cell fate.. 16:3-10. 1997
- APOPTOSIS - CELL-DEATH OR SUICIDE - THIS IS THE PROBLEM. 14:275-281. 1995
- FIBRONECTIN AND VITRONECTIN ADHESION ENHANCEMENT DURING CELLS DIFFERENTIATION-INDUCED BY IL-6 AND LIF. 13:339-348. 1994
- ADHESION TO SOME EXTRACELLULAR-MATRIX COMPONENTS OF HEAT-TREATED HTC HEPATOMA-CELLS. 13:145-149. 1994